BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26467173)

  • 1. A Novel Mutation on RAF1 in Association with Fetal Findings Suggestive of Noonan Syndrome.
    Kneitel AW; Norby A; Vettraino I; Treadwell MC
    Fetal Pediatr Pathol; 2015; 34(6):361-4. PubMed ID: 26467173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of hypoplastic left heart syndrome associated with Noonan Syndrome and de novo RAF1 mutation.
    Schulz S; Fröber R; Kraus C; Schneider U
    Prenat Diagn; 2012 Oct; 32(10):1016-8. PubMed ID: 22821648
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline gain-of-function mutations in RAF1 cause Noonan syndrome.
    Razzaque MA; Nishizawa T; Komoike Y; Yagi H; Furutani M; Amo R; Kamisago M; Momma K; Katayama H; Nakagawa M; Fujiwara Y; Matsushima M; Mizuno K; Tokuyama M; Hirota H; Muneuchi J; Higashinakagawa T; Matsuoka R
    Nat Genet; 2007 Aug; 39(8):1013-7. PubMed ID: 17603482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal pulmonary arterial hypertension and Noonan syndrome: two fatal cases with a specific RAF1 mutation.
    Hopper RK; Feinstein JA; Manning MA; Benitz W; Hudgins L
    Am J Med Genet A; 2015 Apr; 167A(4):882-5. PubMed ID: 25706034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel RAF1 mutation p.(Gly361Ala) located outside the kinase domain of the CR3 region in two patients with Noonan syndrome, including one with a rare brain tumor.
    Harms FL; Alawi M; Amor DJ; Tan TY; Cuturilo G; Lissewski C; Brinkmann J; Schanze D; Kutsche K; Zenker M
    Am J Med Genet A; 2018 Feb; 176(2):470-476. PubMed ID: 29271604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings.
    Croonen EA; Nillesen WM; Stuurman KE; Oudesluijs G; van de Laar IM; Martens L; Ockeloen C; Mathijssen IB; Schepens M; Ruiterkamp-Versteeg M; Scheffer H; Faas BH; van der Burgt I; Yntema HG
    Eur J Hum Genet; 2013 Sep; 21(9):936-42. PubMed ID: 23321623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A severe clinical phenotype of Noonan syndrome with neonatal hypertrophic cardiomyopathy in the second case worldwide with RAF1 S259Y neomutation.
    Jaouadi H; Chehida AB; Kraoua L; Etchevers HC; Argiro L; Kasdallah N; Blibech S; Delague V; Lévy N; Tebib N; Mrad R; Abdelhak S; Benkhalifa R; Zaffran S
    Genet Res (Camb); 2019 Apr; 101():e6. PubMed ID: 31030682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype.
    Bakker M; Pajkrt E; Mathijssen IB; Bilardo CM
    Prenat Diagn; 2011 Sep; 31(9):833-40. PubMed ID: 21706501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A boy with Burkitt lymphoma associated with Noonan syndrome due to a mutation in RAF1.
    Cianci P; Tono V; Sala A; Locatelli L; Carta C; Rizzari C; Biondi A; Selicorni A
    Am J Med Genet A; 2013 Jun; 161A(6):1401-4. PubMed ID: 23613113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of Noonan syndrome in fetuses with increased nuchal translucency and a normal karyotype.
    Matyášová M; Dobšáková Z; Hiemerová M; Kadlecová J; Nikulenkov Grochová D; Popelínská E; Svobodová E; Vlašín P
    Ceska Gynekol; 2019; 84(3):195-200. PubMed ID: 31324109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations.
    Longoni M; Moncini S; Cisternino M; Morella IM; Ferraiuolo S; Russo S; Mannarino S; Brazzelli V; Coi P; Zippel R; Venturin M; Riva P
    Am J Med Genet A; 2010 Sep; 152A(9):2176-84. PubMed ID: 20683980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHENOTYPIC CONSEQUENCES AND THE MALIGNANCY RISK IN FAMILIAL NOONAN SYNDROME DUE TO A RARE P.S427G RAF1 MUTATION.
    Pelc M; Ciara E; Jezela-Stanek A; Krajewska-Walasek M
    Genet Couns; 2016; 27(3):325-333. PubMed ID: 30204961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.
    Ghedira N; Lagarde A; Ben Ameur K; Elouej S; Sakka R; Kerkeni E; Chioukh FZ; Olschwang S; Desvignes JP; Abdelhak S; Delague V; Lévy N; Monastiri K; De Sandre-Giovannoli A
    BMC Pediatr; 2018 Aug; 18(1):286. PubMed ID: 30157809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.
    Kobayashi T; Aoki Y; Niihori T; Cavé H; Verloes A; Okamoto N; Kawame H; Fujiwara I; Takada F; Ohata T; Sakazume S; Ando T; Nakagawa N; Lapunzina P; Meneses AG; Gillessen-Kaesbach G; Wieczorek D; Kurosawa K; Mizuno S; Ohashi H; David A; Philip N; Guliyeva A; Narumi Y; Kure S; Tsuchiya S; Matsubara Y
    Hum Mutat; 2010 Mar; 31(3):284-94. PubMed ID: 20052757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal DNA diagnosis of Noonan syndrome in a fetus with massive hygroma colli, pleural effusion and ascites.
    Schlüter G; Steckel M; Schiffmann H; Harms K; Viereck V; Emons G; Burfeind P; Pauer HU
    Prenat Diagn; 2005 Jul; 25(7):574-6. PubMed ID: 16032767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants.
    Wu X; Yin J; Simpson J; Kim KH; Gu S; Hong JH; Bayliss P; Backx PH; Neel BG; Araki T
    Mol Cell Biol; 2012 Oct; 32(19):3872-90. PubMed ID: 22826437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
    Dereure O
    Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.
    Yin JC; Platt MJ; Tian X; Wu X; Backx PH; Simpson JA; Araki T; Neel BG
    Nat Commun; 2017 May; 8():15518. PubMed ID: 28548091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.